Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

Authors: Uwe Reuter, Peter J. Goadsby, Michel Lantéri‐Minet, Shihua Wen, Peggy Hours-Zesiger, Michel D. Ferrari, Jan Klatt - The Lancet 2018 cited by 470